EUVIMEDEUVIMED entdecken
Leserbrief

Potential Associations Between GLP ‐1 Receptor Agonists and Polyendocrine Metabolic Ovarian Syndrome: Triangulation of Genetic and Pharmacovigilance Evidence

Zeying Feng, Huilin Lian, Chong Liu, Yingmei Shi, Chenjie He, Shu Li, Qiuyan Liang, Jingjing Li iD

Diabetes, Obesity and Metabolism · 2026-12 · 28 (12) · 12004-12008

DOI: 10.1111/dom.71348 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 14.09.2026. Verfasst von Zeying Feng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Trial Institution Office, Liuzhou Hospital of Guangzhou Women and Children's Medical Center, Liuzhou, China. Die Arbeit nennt 10 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Liuzhou Key Laboratory of Clinical Drug Research and Evaluation for Women and Children; the Guangxi Science and Technology Plan Project, Guangxi Clinical Resea…, Project of the Liuzhou Science and Technology Bureau, Liuzhou Key Laboratory for Diagnosis and Treatment of Infertility related to Polycystic Ovary Syndrome.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

GLP‐1liraglutidepregnancyreal‐world evidencesemaglutide

Autor:innen und Institutionen

  • Clinical Trial Institution Office, Liuzhou Hospital of Guangzhou Women and Children's Medical Center, Liuzhou, China.
  • Liuzhou Key Laboratory of Clinical Drug Research and Evaluation for Women and Children, Liuzhou, China.
  • Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, China.
  • Liuzhou Hospital of Guangzhou Women and Children's Medical Center, Liuzhou, China.
  • Department of Gynecology, Liuzhou Maternity and Child Healthcare Hospital, Liuzhou, China.
  • Liuzhou Key Laboratory for Diagnosis and Treatment of Infertility Related to Polycystic Ovary Syndrome, Liuzhou, China.

ORCID-Profile: Jingjing Li

Förderung

  • National Natural Science Foundation of China
  • Liuzhou Key Laboratory of Clinical Drug Research and Evaluation for Women and Children; the Guangxi Science and Technology Plan Project, Guangxi Clinical Resea…
  • Project of the Liuzhou Science and Technology Bureau, Liuzhou Key Laboratory for Diagnosis and Treatment of Infertility related to Polycystic Ovary Syndrome
  • Liuzhou City Science and Technology Planning Project

Zitieren

APA

Feng, Z., Lian, H., Liu, C., Shi, Y., He, C., Li, S., Liang, Q., & Li, J. (2026). Potential Associations Between GLP ‐1 Receptor Agonists and Polyendocrine Metabolic Ovarian Syndrome: Triangulation of Genetic and Pharmacovigilance Evidence. Diabetes, Obesity and Metabolism, 28(12), 12004-12008. https://doi.org/10.1111/dom.71348

Vancouver

Feng Z, Lian H, Liu C, Shi Y, He C, Li S, et al. Potential Associations Between GLP ‐1 Receptor Agonists and Polyendocrine Metabolic Ovarian Syndrome: Triangulation of Genetic and Pharmacovigilance Evidence. Diabetes, Obesity and Metabolism. 2026;28(12):12004-12008. doi:10.1111/dom.71348

BibTeX
@article{Feng2026,
  author = {Feng, Zeying and Lian, Huilin and Liu, Chong and Shi, Yingmei and He, Chenjie and Li, Shu and Liang, Qiuyan and Li, Jingjing},
  title = {Potential Associations Between GLP ‐1 Receptor Agonists and Polyendocrine Metabolic Ovarian Syndrome: Triangulation of Genetic and Pharmacovigilance Evidence},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {12},
  pages = {12004--12008},
  doi = {10.1111/dom.71348}
}
Kostenlos starten →